ROYAL BANK OF CANADA - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 33 filers reported holding NRX PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$0
-100.0%
125
-99.9%
0.00%
Q4 2023$69,000
+56.8%
150,209
-11.9%
0.00%
Q3 2023$44,000
-47.0%
170,419
-0.5%
0.00%
Q2 2023$83,000171,233
+135799.2%
0.00%
Q1 2023$0126
-1.6%
0.00%
Q4 2022$0128
-59.7%
0.00%
Q3 2022$0318
-39.2%
0.00%
Q2 2022$0
-100.0%
523
-93.5%
0.00%
Q2 2021$93,0008,0000.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 642,632$295,6110.07%
One Wealth Management Investment & Advisory Services, LLC 140,402$64,5850.03%
Texas Capital Bank Wealth Management Services Inc 63,290$29,1130.00%
HighPoint Advisor Group LLC 43,501$23,0000.00%
HBK Sorce Advisory LLC 29,230$13,4460.00%
United Asset Strategies, Inc. 18,300$8,4180.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 122,700$56,4420.00%
NORTHERN TRUST CORP 74,996$34,4980.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 46,837$21,5450.00%
View complete list of NRX PHARMACEUTICALS INC shareholders